Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 77

    Lupin ropes in Jon Stelzmiller to head US specialty business

    Lupin ropes in Jon Stelzmiller to head US specialty business

    Medical Dialogues Bureau26 Sept 2019 4:54 PM IST
    New Delhi: Homegrown pharma major Lupin on Wednesday announced appointment of Jon Stelzmiller as the President of its US specialty business....
    GSK decides to recall antacid Zinetac over safety concern

    GSK decides to recall antacid Zinetac over safety concern

    Medical Dialogues Bureau26 Sept 2019 4:54 PM IST
    New Delhi: GlaxoSmithKline Pharmaceuticals Ltd on Wednesday announced recall of ranitidine hydrochloride tablets produced in India using API sourced...
    Onco.com, dedicated cancer care platform, raises $7 million in Series A funding

    Onco.com, dedicated cancer care platform, raises $7 million in Series A funding

    Medical Dialogues Bureau26 Sept 2019 4:54 PM IST
    Bengaluru,: Onco.com, India's only internet aggregator for cancer care, announced completion of $7 million in series A funding by Accel, Chiratae...
    Alembic JV Aleor Derma gets 1 USFDA observation for Karakhadi facility

    Alembic JV Aleor Derma gets 1 USFDA observation for Karakhadi facility

    Medical Dialogues Bureau25 Sept 2019 1:53 PM IST
    Aleor Derma's formulation manufacturing facility located at Karakhadi, Gujarat got one observation after the completion of USFDA inspection. The...
    Zydus Cadila: USFDA classifies Ankleshwar facility as No Action Indicated

    Zydus Cadila: USFDA classifies Ankleshwar facility as No Action Indicated

    Medical Dialogues Bureau25 Sept 2019 9:45 AM IST
    The US Food and Drug Administration (USFDA) had conducted an inspection at the facility from July 22-26, 2019. The EIR report stated that the...
    Anuh Pharma successfully clears USFDA inspection

    Anuh Pharma successfully clears USFDA inspection

    Medical Dialogues Bureau25 Sept 2019 9:30 AM IST
    "We are pleased to inform you that a successful accomplishment at Anuh Pharma Ltd. was inspected by USFDA (United States Food and Drug Administration)...
    Cipla employee settles case with SEBI, pays Rs 3 lakh

    Cipla employee settles case with SEBI, pays Rs 3 lakh

    Medical Dialogues Bureau25 Sept 2019 9:25 AM IST
    SEBI, during its preliminary examination, observed that there was a delay on the part of Pathak in making a disclosure to the company under SEBI's PIT...
    13 medical outlets violate provisions of Drugs and Cosmetics Act, licenses suspended

    13 medical outlets violate provisions of Drugs and Cosmetics Act, licenses suspended

    Farhat Nasim25 Sept 2019 9:00 AM IST
    Licenses of the erring establishments -- five in Jammu city, three at Bari Brahmna and five at R S Pura -- were suspended for violating provisions of...
    Biocon acquires Pfizer RnD facility to boost biosimilars portfolio

    Biocon acquires Pfizer RnD facility to boost biosimilars portfolio

    Farhat Nasim24 Sept 2019 3:44 PM IST
    Biocon Biologics has acquired Research and Development(RnD) capital assets from Pfizer Healthcare India Ltd.New Delhi: Biopharmaceuticals company,...
    Lupin Tarapur API facility gets 3 observations from USFDA

    Lupin Tarapur API facility gets 3 observations from USFDA

    Medical Dialogues Bureau24 Sept 2019 9:45 AM IST
    The inspection of the Tarapur facility was carried out by the US health regulator between September 16 to September 20, 2019, said Lupin.Mumbai:...
    Laurus Labs to acquire subsidiary of ASPEN Pharmacare

    Laurus Labs to acquire subsidiary of ASPEN Pharmacare

    Farhat Nasim24 Sept 2019 9:30 AM IST
    "The completion of conditions precedent, by way of cash consideration of ZAR 75,000, the Pharmaceutical company said in a statement here. The...
    Indoco Remedies sterile manufacturing plant in Goa gets 2 observations from UK-MHRA

    Indoco Remedies sterile manufacturing plant in Goa gets 2 observations from UK-MHRA

    Medical Dialogues Bureau24 Sept 2019 9:17 AM IST
    'The successful closure of the MHRA inspection is encouraging and reflects the immense learning and adaption by our technical team. The Sterile...
    PrevNext

    Popular Stories

    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

    Biocon Biologics appoints M B Chinappa as Chief Financial Officer

    Biocon Biologics appoints M B Chinappa as Chief Financial Officer

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Protect Your Loved Ones with a Term Plan that’s Smart

    Protect Your Loved Ones with a Term Plan that’s Smart

    Lupin posts net loss at Rs 835 crore in Q3

    Lupin posts net loss at Rs 835 crore in Q3

    Illumina Files Additional Patent Infringement Suit Against BGI in the U.S.

    Illumina Files Additional Patent Infringement Suit Against BGI in the U.S.

    Mediclaim cannot be denied on presumption of pre-existing disease: NCDRC

    Mediclaim cannot be denied on presumption of pre-existing disease: NCDRC

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok